» Authors » Hans-Michael Tautenhahn

Hans-Michael Tautenhahn

Explore the profile of Hans-Michael Tautenhahn including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 45
Citations 303
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Pfister F, Mehdorn M, Schwartner C, Seehofer D, Tautenhahn H, Struck M, et al.
Abdom Radiol (NY) . 2024 Mar; 49(5):1376-1384. PMID: 38528270
Purpose: Contrast enhancement of the adrenal gland defined by computed tomography (CT) was previously analyzed as a prognostic factor for critically ill patients in various diseases. However, no study investigated...
12.
Lambers L, Waschinsky N, Schleicher J, Konig M, Tautenhahn H, Albadry M, et al.
Biomech Model Mechanobiol . 2024 Feb; 23(2):631-653. PMID: 38402347
Metabolic zonation refers to the spatial separation of metabolic functions along the sinusoidal axes of the liver. This phenomenon forms the foundation for adjusting hepatic metabolism to physiological requirements in...
13.
Rauchfuss F, Tautenhahn H, Dondorf F, Ali-Deeb A, Settmacher U
Ann Transplant . 2023 Mar; 28:e938132. PMID: 36927714
BACKGROUND There are still many offered donor livers that are declined during the allocation process. Machine perfusion offers the option to evaluate (especially marginal) donor organs and to better decide...
14.
Tautenhahn H, Kindler E, Volmer K, Zipprich A, Settmacher U
Chirurgie (Heidelb) . 2023 Jan; 94(1):28-35. PMID: 36633652
Due to the demographic changes and the increasing incidence of chronic, especially nutritively toxic liver diseases, the number of patients over 65 years of age with indications for liver transplantation...
15.
Tautenhahn H, Nickel S, Kindler E, Settmacher U
Chirurgie (Heidelb) . 2022 Jun; 93(7):652-658. PMID: 35771270
Depending on the patient's constitution, the biological conditions of the primary tumor, the metastases and the liver function and perfusion, a variety of therapeutic options are available. The basis of...
16.
Xu F, Tautenhahn H, Dirsch O, Dahmen U
J Cancer Res Clin Oncol . 2022 Jun; 148(12):3243-3256. PMID: 35695930
Purpose: The autophagy inhibitor chloroquine enhances the effect of targeted therapy using tyrosine kinase inhibitor in liver cancer. We would like to further understand the specific mechanism by which chloroquine...
17.
Mazzola A, Pittau G, Hong S, Chinnakotla S, Tautenhahn H, Maluf D, et al.
Clin Transplant . 2022 Apr; 36(10):e14677. PMID: 35429941
Background: Few data are available on discharge criteria after living liver donation (LLD). Objectives: To identify the features for fit for discharge checklist after LLD to prevent unnecessary re-hospitalizations and...
18.
Koller A, Grzegorzewski J, Tautenhahn H, Konig M
Front Physiol . 2021 Dec; 12:730418. PMID: 34880771
The evaluation of hepatic function and functional capacity of the liver are essential tasks in hepatology as well as in hepatobiliary surgery. Indocyanine green (ICG) is a widely applied test...
19.
Christ B, Collatz M, Dahmen U, Herrmann K, Hopfl S, Konig M, et al.
Front Physiol . 2021 Dec; 12:733868. PMID: 34867441
Liver resection causes marked perfusion alterations in the liver remnant both on the organ scale (vascular anatomy) and on the microscale (sinusoidal blood flow on tissue level). These changes in...
20.
Nickel S, Vlaic S, Christ M, Schubert K, Henschler R, Tautenhahn F, et al.
NPJ Regen Med . 2021 Dec; 6(1):84. PMID: 34862411
Post-surgery liver failure is a serious complication for patients after extended partial hepatectomies (ePHx). Previously, we demonstrated in the pig model that transplantation of mesenchymal stromal cells (MSC) improved circulatory...